References
Rogaeva EA, Fafel KC, Song YQ, Medeiros H, Sato C, Liang Y, Richard E, Rogaev EI, Frommelt P, Sadovnick AD, Meschino W, Rockwood K, Boss MA, Mayeux R, St George-Hyslop P (2001) Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology 57:621–625
Raux G, Guyant-Marechal L, Martin C, Bou J, Penet C, Brice A, Hannequin D, Frebourg T, Campion D (2005) Molecular diagnosis of autosomal dominant early onset Alzheimer’s disease: an update. J Med Genet 42:793–795. doi:10.1136/jmg.2005.033456
Ikeuchi T, Kaneko H, Miyashita A, Nozaki H, Kasuga K, Tsukie T, Tsuchiya M, Imamura T, Ishizu H, Aoki K, Ishikawa A, Onodera O, Kuwano R, Nishizawa M (2008) Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations. Dement Geriatr Cogn Disord 26:43–49. doi:10.1159/000141483
Larner AJ, Doran M (2006) Clinical phenotypic heterogeneity of Alzheimer’s disease associated with mutations of the presenilin-1 gene. J Neurol 253:139–158. doi:10.1007/s00415-005-0019-5
Kim KW, Lee DY, Jhoo JH, Youn JC, Suh YJ, Jun YH, Seo EH, Woo JI (2005) Diagnostic accuracy of mini-mental status examination and revised hasegawa dementia scale for Alzheimer’s disease. Dement Geriatr Cogn Disord 19:324–333. doi:10.1159/000084558
Ikeuchi T, Dolios G, Kim SH, Wang R, Sisodia SS (2003) Familial Alzheimer disease-linked presenilin 1 variants enhance production of both Aβ1-40 and Aβ1-42 peptides that are only partially sensitive to a potent aspartyl protease transition state inhibitor of γ-secretase. J Biol Chem 278:7010–70187. doi:10.1074/jbc.M209252200
Kaneko H, Kakita A, Kasuga K, Nozaki H, Ishikawa A, Miyashita A, Kuwano R, Ito G, Iwatsubo T, Takahashi H, Nishizawa M, Onodera O, Sisodia SS, Ikeuchi T (2007) Enhanced accumulation of phosphorylated α-synuclein and elevated β-amyloid 42/40 ratio caused by expression of the presenilin-1 ΔT440 associated with familial Lewy body disease and variant Alzheimer’s disease. J Neurosci 27:13092–13097. doi:10.1523/JNEUROSCI.4244-07.2007
Tedde A, Forleo P, Nacmias B, Piccini C, Bracco L, Piacentini S, Sorbi S (2000) A presenilin-1 mutation (Leu392Pro) in a familial AD kindred with psychiatric symptoms at onset. Neurology 55:1590–1591
Harvey RJ, Ellison D, Hardy J, Mutton M, Roques PK, Collinge J, Fox NC, Rossor MN (1998) Chromosome 14 familial Alzheimer’s disease: the clinical and neuropathological characteristics of a family with a leucine → serine (L250S) substitution at codon 250 of the presenilin 1 gene. J Neurol Neurosurg Psychiatr 64:44–49. doi:10.1136/jnnp.64.1.44
Ringman JM, Diaz-Olavarrieta C, Rodriguez Y, Chavez M, Paz F, Murrell J, Macias MA, Hill M, Kawas C (2004) Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin. J Neurol Neurosurg Psychiatr 75:500–502. doi:10.1136/jnnp.2002.005025
Acknowledgments
This study was supported in part by a Grant-in-Aid for Scientific Research (20590990) from MEXT, Japan and Kanehara Ichiro Memorial Foundation
Conflict of interest statement
The authors have reported no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kasuga, K., Ohno, T., Ishihara, T. et al. Depression and psychiatric symptoms preceding onset of dementia in a family with early-onset Alzheimer disease with a novel PSEN1 mutation. J Neurol 256, 1351–1353 (2009). https://doi.org/10.1007/s00415-009-5096-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-5096-4